Related references
Note: Only part of the references are listed.Epstein-Barr virus and multiple sclerosis: interaction with HLA
E. Sundqvist et al.
GENES AND IMMUNITY (2012)
Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease
Emily M. L. Chastain et al.
IMMUNOLOGICAL REVIEWS (2012)
Interferon signatures in immune disorders and disease
Samuel Forster
IMMUNOLOGY AND CELL BIOLOGY (2012)
Cytosolic RIG-I-like helicases act as negative regulators of sterile inflammation in the CNS
Angela Dann et al.
NATURE NEUROSCIENCE (2012)
IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells
Cheryl M. Sweeney et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis
S. Vosslamber et al.
GENES AND IMMUNITY (2011)
IFN-α Mediates the Development of Autoimmunity both by Direct Tissue Toxicity and through Immune Cell Recruitment Mechanisms
Nagako Akeno et al.
JOURNAL OF IMMUNOLOGY (2011)
RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
Laura Codarri et al.
NATURE IMMUNOLOGY (2011)
Interferon-β exacerbates Th17-mediated inflammatory disease
Robert C. Axtell et al.
TRENDS IN IMMUNOLOGY (2011)
LOX-1 as a natural IFN-α-mediated signal for apoptotic cell uptake and antigen presentation in dendritic cells
Stefania Parlato et al.
BLOOD (2010)
Redefining the role of interferon in the treatment of malignant diseases
Sergio Bracarda et al.
EUROPEAN JOURNAL OF CANCER (2010)
Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance
Melissa Swiecki et al.
IMMUNOLOGICAL REVIEWS (2010)
On the Role of Aggregates in the Immunogenicity of Recombinant Human Interferon Beta in Patients with Multiple Sclerosis
Miranda M. C. van Beers et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
Robert C. Axtell et al.
NATURE MEDICINE (2010)
T-Helper 17 Cells Expand in Multiple Sclerosis and Are Inhibited by Interferon-β
Luca Durelli et al.
ANNALS OF NEUROLOGY (2009)
Genome-wide Scan of 500 000 Single-Nucleotide Polymorphisms Among Responders and Nonresponders to Interferon Beta Therapy in Multiple Sclerosis
Manuel Comabella et al.
ARCHIVES OF NEUROLOGY (2009)
CCR2Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system
Alexander Mildner et al.
BRAIN (2009)
Innate immunity to virus infection
Osamu Takeuchi et al.
IMMUNOLOGICAL REVIEWS (2009)
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
M. Paula Longhi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
IFN-β Inhibits Human Th17 Cell Differentiation
Vinod S. Ramgolam et al.
JOURNAL OF IMMUNOLOGY (2009)
Innate and Adaptive Autoimmunity Directed to the Central Nervous System
Roopa Bhat et al.
NEURON (2009)
Genome-wide pharmacogenomic analysis of the response to interferon β therapy in multiple sclerosis
Esther Byun et al.
ARCHIVES OF NEUROLOGY (2008)
TRADD protein is an essential component of the RIG-like helicase antiviral pathway
Marie-Cecile Michallet et al.
IMMUNITY (2008)
Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system
Marco Prinz et al.
IMMUNITY (2008)
The type IIFN induction pathway constrains Th17-mediated autoimmune inflammation in mice
Beichu Guo et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition
Mark A. Kroenke et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells
Ingunn M. Stromnes et al.
NATURE MEDICINE (2008)
Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells
Denise C. Fitzgerald et al.
NATURE IMMUNOLOGY (2007)
Using measurements of neutralizing antibodies:: the challenge of IFN-β therapy
D. Hesse et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Differentiation and function of Th17 T cells
Brigitta Stockinger et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Interferons in multiple sclerosis: Ten years' experience
Ayman Tourbah et al.
BIOCHIMIE (2007)
Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia
Elisabeth Kamphuis et al.
BLOOD (2006)
Microarray analysis identifies a set of CXCR3 and CCR2 ligand chemokines as early IFNβ-responsive genes in peripheral blood lymphocytes in vitro:: an implication for IFNβ-related adverse effects in multiple sclerosis
Jun-ichi Satoh et al.
BMC NEUROLOGY (2006)
Psychiatric side effects of interferon-β in multiple sclerosis
JL Goeb et al.
EUROPEAN PSYCHIATRY (2006)
Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection
Elizabeth S. Coro et al.
JOURNAL OF IMMUNOLOGY (2006)
CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
LR Shiow et al.
NATURE (2006)
Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients
J Río et al.
ANNALS OF NEUROLOGY (2006)
Type I inteferon gene induction by the interferon regulatory factor family of transcription factors
Kenya Honda et al.
IMMUNITY (2006)
Pharmacogenomics of responsiveness to interferon IFN-β treatment in multiple sclerosis:: A genetic screen of 100 type I interferon-inducible genes
S Cunningham et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
LE Harrington et al.
NATURE IMMUNOLOGY (2005)
Cutting edge: Type IIFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation
JM Curtsinger et al.
JOURNAL OF IMMUNOLOGY (2005)
IL-10 promoter haplotype influence on interferon treatment response in multiple sclerosis
S Wergeland et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to listeria infection
JA Carrero et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Escalating immunotherapy of multiple sclerosis -: New aspects and practical application
C Bassetti et al.
JOURNAL OF NEUROLOGY (2004)
IFN-β gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis
I Teige et al.
JOURNAL OF IMMUNOLOGY (2003)
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
C Lock et al.
NATURE MEDICINE (2002)
Complex immunomodulatory effects of interferon-β in multiple sclerosis include the upregulation of T helper 1-associated marker genes
KP Wandinger et al.
ANNALS OF NEUROLOGY (2001)
Share Paper
